ctrl K

Amylyx Pharmaceuticals In... (AMLX)

NASDAQ: AMLX · Real-Time Price · USD

5.33

0.19 (3.70%)

At close: May 02, 2025, 3:04 PM

Amylyx Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	77.39M	170.2M	62.53M	50.19M	12.88M	3.09M
Short-Term Investments	99.11M	201.16M	284.42M	45.93M	n/a	n/a
Long-Term Investments	n/a	n/a	719K	189K	189K	n/a
Other Long-Term Assets	1.47M	46.38M	466K	3.44M	125K	18K
Receivables	447K	40.05M	15.31M	n/a	n/a	n/a
Inventory	n/a	38.32M	9.77M	n/a	n/a	n/a
Other Current Assets	12.48M	14.93M	10.11M	3.44M	n/a	26K
Total Current Assets	189.43M	464.67M	382.13M	101.51M	13.64M	3.2M
Property-Plant & Equipment	2.73M	6.41M	8.13M	474K	151K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.2M	52.79M	9.32M	4.1M	465K	18K
Total Assets	193.63M	517.45M	391.45M	105.61M	14.1M	3.22M
Account Payables	2.94M	22.06M	6.26M	4.37M	3.61M	2.19M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.52M	n/a	2.04M	n/a	n/a	n/a
Other Current Liabilities	23.95M	40.93M	21.04M	n/a	n/a	n/a
Total Current Liabilities	28.41M	82.04M	46.61M	17.4M	7.33M	4.53M
Long-Term Debt	n/a	n/a	n/a	n/a	1.43M	14.93M
Other Long-Term Liabilities	n/a	n/a	n/a	35K	72.06M	9.11M
Total Long-Term Liabilities	463K	1.98M	4.24M	239.39M	73.5M	24.05M
Total Liabilities	28.87M	84.02M	50.85M	256.78M	80.83M	28.58M
Total Debt	1.98M	4.24M	6.28M	n/a	1.43M	14.93M
Common Stock	7K	7K	7K	1K	1K	1K
Retained Earnings	-606.69M	-304.95M	-354.22M	-155.84M	-67.91M	-25.63M
Comprehensive Income	-92K	197K	-86K	9K	-72.06M	-7.67M
Shareholders Equity	164.76M	433.43M	340.61M	-151.17M	-66.72M	-25.36M
Total Investments	99.11M	201.16M	284.42M	45.93M	189K	n/a